Matthew Charles Mc Murdo is Director of TITAN PHARMACEUTICALS INC. Currently has a direct ownership of 66,250 shares of TTNP, which is worth approximately $223,925. The most recent transaction as insider was on Oct 25, 2023, when has been sold 16,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.3K
0% 3M change
0% 12M change
Total Value Held $223,925

Matthew Charles McMurdo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 25 2023
BUY
Grant, award, or other acquisition
-
16,250 Added 19.7%
66,250 Common Stock
Jul 26 2023
BUY
Grant, award, or other acquisition
-
50,000 Added 50.0%
50,000 Common Stock

Also insider at

OPGN
OPGEN INC Healthcare
MINM
MINIM, INC. Technology
MCM

Matthew Charles Mc Murdo

Director
Westfield, NJ

Track Institutional and Insider Activities on TTNP

Follow TITAN PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TTNP shares.

Notify only if

Insider Trading

Get notified when an Titan Pharmaceuticals Inc insider buys or sells TTNP shares.

Notify only if

News

Receive news related to TITAN PHARMACEUTICALS INC

Track Activities on TTNP